Short-term branched-chain amino acid supplementation does not enhance vertical jump in professional volleyball players. A double-blind, controlled, randomized study.

INTRODUCTION: To the best of the authors' knowledge, no previous studies have described the effect of branched-chain amino acids (BCAA) on vertical performance during a week in professional volleyball players. This study assessed BCAA supplementation for a week, aiming to improve vertical jump performance in male professional volleyball players. Twelve male volleyballers were randomly assigned to a BCAA group (n = 6) or a control group (n = 6). The BCAA group ingested 21 g over a week, 7 g per day on Monday, Wednesday, and Friday, before a volleyball training session, while the control group drank a placebo drink. Participants performed 8 maximal countermovement jumps (CMJ); the 3 CMJs on Monday and Wednesday were evaluated after warm-up, after plyometric training, and at the end of the training session; and the 2 CMJs on Friday were evaluated after warm-up, and at the end of the training session. Compared with baseline, no significant differences in CMJ over the week were observed in BCAA or control group, neither between groups. The results indicated that 21 g of BCAA supplementation over a week did not improve vertical jump performance in professional volleyball players.

INTRODUCCIÓN: Hasta donde los autores saben, no se han descrito estudios previos sobre el efecto de los aminoácidos ramificados (BCAA) en el rendimiento vertical durante una semana en jugadores de voleibol profesionales. Este artículo estudió la suplementación de BCAA durante una semana con el objeto de mejorar el rendimiento del salto vertical en jugadores de voleibol profesionales masculinos. Doce jugadores de voleibol masculinos se asignaron aleatoriamente a un grupo con BCAA (n = 6) o a un grupo de control (n = 6). El grupo con BCAA ingirió 21 g en una semana, 7 g por día los lunes, miércoles y viernes antes de la sesión de entrenamiento de voleibol, mientras que el grupo de control bebió una bebida placebo. Los participantes realizaron 8 saltos máximos de contramovimiento (CMJ); los 3 CMJ de lunes y miércoles se evaluaron después del calentamiento y del entrenamiento pliométrico, y al final de la sesión de entrenamiento; los 2 CMJ del viernes se evaluaron después del calentamiento y al final de la sesión de entrenamiento. En comparación con el valor inicial, no se observaron diferencias significativas en los CMJ a lo largo de la semana, ni en el grupo BCAA ni en el grupo control, tampoco hubo diferencias entre grupos. Los resultados indicaron que 21 g de BCAA administrados durante una semana no mejoraron el rendimiento del salto vertical en jugadores de voleibol profesionales.

Impact of cognitive tasks on biomechanical and kinematic parameters of gait in women with fibromyalgia: A cross-sectional study.

BACKGROUND: Fibromyalgia (FM) is a chronic disease whose symptoms may cause altered walking pattern, which is important given the relevance of walking in daily life activities. These activities use to require the ability to perform both a motor and a cognitive task simultaneously. The main aim of the current study was to evaluate the impact of performing a simultaneous cognitive task in the gait pattern of women with FM. METHODS: A total of 36 women recruited from a local association took part in this cross-sectional study. The time required to complete the 10-meters-walking-test and kinematic outcomes including number of steps, cadence, trunk tilt and ranges of motion were analyzed under single (motor task only) and dual task (motor and cognitive tasks simultaneously) conditions. The secondary task consisted in counting aloud backward in rows of two. RESULTS: Results showed a significant increment in the time required to complete the test (p < 0.01) when participants performed the motor and cognitive tasks at the same time. Moreover, relevant changes in kinematic parameters such as increment of number of steps (p < 0.01), cadence (p < 0.01), trunk tilt (p < 0.01) and both hip (p < 0.01) and knee (p = 0.03) ranges of motion were also observed. CONCLUSION: Adding a cognitive task to a primary motor task affects the walking motor pattern in women with FM, making it more stable and safer walking pattern when the attention is focused on two simultaneous tasks.

Reliability of the 30 s Chair Stand Test in Women with Fibromyalgia.

Background: The 30 s chair stand test is often used to evaluate physical fitness in chronic pain populations. In patients with fibromyalgia, physical fitness is closely related to pain, quality of life, and fear of falling. However, the reliability of this test has only been evaluated concerning the number of repetitions. Objective: To evaluate the test-retest reliability of the 30 s chair stand test in women with fibromyalgia (n = 30), using data from the contact and non-contact time registered with an automatic chronometer (chronojump). Methods: Participants carried out the 30 s chair stand test twice with five minutes as a rest period, while an automatic chronometer recorded the time elapsed in contact with the chair (impulse phase) and not in contact (non-contact phase). Number and fear of falls in the last year and in the last six weeks were also recorded. Results: The reliability of duration of both phases was good. A relationship between these results and the number and fear of falling was also found. Conclusion: The analysis of movement phases in the 30 s chair stand test showed a good reliability in females with fibromyalgia, providing further useful information about the onset of muscle fatigue during the test.

Effects of 24-week exergame intervention on physical function under single- and dual-task conditions in fibromyalgia: A randomized controlled trial.

OBJECTIVE: To evaluate the effects of 24-week exergame intervention in the physical fitness of women with fibromyalgia in both single- and dual-task conditions. DESIGN: Single-blinded, randomized controlled trial. SETTING: University facilities. PARTICIPANTS: Fifty-five women with fibromyalgia, recruited from the local fibromyalgia association, were randomly assigned to one of the two groups: exercise group and control group. INTERVENTION: The exercise group completed 24 weeks of supervised and group-based exergame protocol, divided into two sessions of 60 minutes. The intervention was focused on mobility, postural control, upper and lower limbs coordination, aerobic fitness, and strength. MAIN OUTCOME MEASURES: The strength of the upper limbs was measured using the arm curl test. The mobility skill was assessed through the timed-up and go test, and the flexibility of both upper and lower limbs was measured using the back scratch and the sit and reach tests, respectively. RESULTS: Fifty participants completed the study. In the single-task condition, exergame intervention led to significantly higher effects in the arm curl test (P = 0.008), sit and reach test (P = 0.033), and timed-up and go test (P = 0.021). Moreover, under dual-task condition, exergames led to significant effects in all the physical fitness tests (arm curl test, timed-up and go test, back scratch test, and sit and reach test) compared to the control group. CONCLUSIONS: Exergame is an effective tool to improve the physical fitness in women with fibromyalgia under single or dual-task conditions.

GANODERMA LUCIDUM IMPROVES PHYSICAL FITNESS IN WOMEN WITH FIBROMYALGIA.

INTRODUCTION: fibromyalgia is a chronic disease characterized by generalized pain, stiffness, poor physical conditioning, non-restorative sleep and poor health-related quality of life. Ganoderma lucidum a type of mushroom that has demonstrated several benefits in different populations. Ceratonia siliqua is a natural therapy rich in antioxidants with potential benefits on health. OBJECTIVE: to evaluate the effects of 6-week treatment of Ganoderma lucidum and Ceratonia siliqua on physical fitness in patients suffering from fibromyalgia. METHODS: sixty-four women with fibromyalgia participated in the study. They took 6 g of Ganoderma lucidum or Ceratonia siliqua per day for 6 weeks. Different fitness tests were selected in order to evaluate functional capacity. RESULTS: after the 6-week treatment period, Ganoderma lucidum significantly improved aerobic endurance, lower body flexibility, and velocity (p < .05). No significant improvement in any physical test was observed in the Ceratonia siliqua group. DISCUSSION AND CONCLUSION: Ganoderma lucidum may improve physical fitness in women with fibromyalgia, whereas, Ceratonia siliqua seemed to be ineffective at increasing physical fitness. These results may indicate that Ganoderma lucidum might be a useful dietary supplement to enhance physical performance of the patients suffering from fibromyalgia.

Introducción: la fibromialgia es una enfermedad crónica caracterizada por dolor crónico general, rigidez, condición física pobre, sueño no reparador y mala calidad de vida relacionada con la salud. Ganoderma lucidum es un tipo de hongo que ha demostrado tener diferentes beneficios en diversas poblaciones. La harina de algarrobo (Ceratonia siliqua) es una fuente natural de antioxidantes con potenciales beneficios para la salud. Objetivo: evaluar los efectos sobre la condición física en mujeres con fibromialgia de un tratamiento de seis semanas con Ganoderma lucidum y compararlos con los de un tratamiento con Ceratonia siliqua. Métodos: sesenta y cuatro mujeres con fibromialgia participaron en el estudio. Se hicieron dos grupos, el primer grupo tomó 6 g diarios de Ganoderma lucidum, mientras que el segundo tomó 6 g diarios de Ceratonia siliqua. Se evaluó la condición física mediante diferentes test físicos validados. Resultados: después de seis semanas de tratamiento, Ganoderma lucidum mejoró significativamente la resistencia aeróbica, la flexibilidad del miembro inferior y la velocidad (p < 0,05). Por otro lado, Ceratonia siliqua no mejoró la condición física. Discusión y conclusiones: Ganoderma lucidum puede mejorar la condición física en mujeres con fibromialgia, mientras que Ceratonia siliqua parece no ser efectivo para este propósito. Estos resultados pueden indicar que 6 g diarios de Ganoderma lucidum podrían ser un suplemento útil para mejorar la condición física en esta población.

Ganoderma lucidum improves physical fitness in women with fibromyalgia / Ganoderma lucidum mejora la condición física en mujeres con fibromialgia

Introduction: fibromyalgia is a chronic disease characterized by generalized pain, stiffness, poor physical conditioning, non-restorative sleep and poor health-related quality of life. Ganoderma lucidum a type of mushroom that has demonstrated several benefits in different populations. Ceratonia siliqua is a natural therapy rich in antioxidants with potential benefits on health. Objective: to evaluate the effects of 6-week treatment of Ganoderma lucidum and Ceratonia siliqua on physical fitness in patients suffering from fibromyalgia. Methods: sixty-four women with fibromyalgia participated in the study. They took 6 g of Ganoderma lucidum or Ceratonia siliqua per day for 6 weeks. Different fitness tests were selected in order to evaluate functional capacity. Results: after the 6-week treatment period, Ganoderma lucidum significantly improved aerobic endurance, lower body flexibility, and velocity (p < .05). No significant improvement in any physical test was observed in the Ceratonia siliqua group. Discussion and conclusion: Ganoderma lucidum may improve physical fitness in women with fibromyalgia, whereas, Ceratonia siliqua seemed to be ineffective at increasing physical fitness. These results may indicate that Ganoderma lucidum might be a useful dietary supplement to enhance physical performance of the patients suffering from fibromyalgia (AU)

Introducción: la fibromialgia es una enfermedad crónica caracterizada por dolor crónico general, rigidez, condición física pobre, sueño no reparador y mala calidad de vida relacionada con la salud. Ganoderma lucidum es un tipo de hongo que ha demostrado tener diferentes beneficios en diversas poblaciones. La harina de algarrobo (Ceratonia siliqua) es una fuente natural de antioxidantes con potenciales beneficios para la salud. Objetivo: evaluar los efectos sobre la condición física en mujeres con fibromialgia de un tratamiento de seis semanas con Ganoderma lucidum y compararlos con los de un tratamiento con Ceratonia siliqua. Métodos: sesenta y cuatro mujeres con fibromialgia participaron en el estudio. Se hicieron dos grupos, el primer grupo tomó 6 g diarios de Ganoderma lucidum, mientras que el segundo tomó 6 g diarios de Ceratonia siliqua. Se evaluó la condición física mediante diferentes test físicos validados. Resultados: después de seis semanas de tratamiento, Ganoderma lucidum mejoró significativamente la resistencia aeróbica, la flexibilidad del miembro inferior y la velocidad (p < 0,05). Por otro lado, Ceratonia siliqua no mejoró la condición física. Discusión y conclusiones: Ganoderma lucidum puede mejorar la condición física en mujeres con fibromialgia, mientras que Ceratonia siliqua parece no ser efectivo para este propósito. Estos resultados pueden indicar que 6 g diarios de Ganoderma lucidum podrían ser un suplemento útil para mejorar la condición física en esta población (AU)